Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reiss

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
The New England Journal of Medicine|July 17, 1998
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstrictionJ A Leff, W W Busse, D Pearlman, et al.
Journal of Hematotherapy|February 1, 1997
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell supportK P Papadopoulos, J Ayello, S Tugulea, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Intermittent or daily montelukast versus placebo for episodic asthma in childrenErkka Valovirta, Maria L Boza, Colin F Robertson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposureTamara T Perry, Jonathan Corren, George Philip, et al.
The European Respiratory Journal|February 7, 2003
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasoneR A Baumgartner, G Martinez, J M Edelman, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaCarlos A Camargo, Deborah M Gurner, Howard A Smithline, et al.
Hematological Oncology|January 26, 2016
Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workersStuart C Finch, Irina Dyagil, Robert F Reiss, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2012
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacksSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
American Journal of Therapeutics|March 31, 1999
Effect of montelukast on single-dose theophylline pharmacokineticsK Malmstrom, J Schwartz, T F Reiss, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|July 17, 1998
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstrictionJ A Leff, W W Busse, D Pearlman, et al.
Journal of Hematotherapy|February 1, 1997
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell supportK P Papadopoulos, J Ayello, S Tugulea, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Intermittent or daily montelukast versus placebo for episodic asthma in childrenErkka Valovirta, Maria L Boza, Colin F Robertson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposureTamara T Perry, Jonathan Corren, George Philip, et al.
The European Respiratory Journal|February 7, 2003
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasoneR A Baumgartner, G Martinez, J M Edelman, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaCarlos A Camargo, Deborah M Gurner, Howard A Smithline, et al.
Hematological Oncology|January 26, 2016
Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workersStuart C Finch, Irina Dyagil, Robert F Reiss, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2012
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacksSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
American Journal of Therapeutics|March 31, 1999
Effect of montelukast on single-dose theophylline pharmacokineticsK Malmstrom, J Schwartz, T F Reiss, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.
Pageof 27